Nuo Therapeutics, Inc.
AURX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $63,594 | $23,143 | $60,002 | $3 |
| - Cash | $284 | $929 | $2,051 | $148 |
| + Debt | $164 | $256 | $335 | $0 |
| Enterprise Value | $63,475 | $22,470 | $58,285 | -$145 |
| Revenue | $1,365 | $609 | $112 | $0 |
| % Growth | 124.3% | 442.1% | – | – |
| Gross Profit | $1,062 | $482 | $93 | $0 |
| % Margin | 77.8% | 79.3% | 82.9% | – |
| EBITDA | -$2,362 | -$3,063 | -$3,096 | $0 |
| % Margin | -173% | -503.4% | -2,757.7% | – |
| Net Income | -$2,324 | -$3,171 | -$3,025 | -$91 |
| % Margin | -170.2% | -521.2% | -2,695.1% | – |
| EPS Diluted | -0.051 | -0.075 | -0.076 | -0.003 |
| % Growth | 32.1% | 0.3% | -2,420% | – |
| Operating Cash Flow | -$2,232 | -$3,168 | -$3,706 | -$13 |
| Capital Expenditures | -$155 | -$7 | -$60 | $0 |
| Free Cash Flow | -$2,387 | -$3,175 | -$3,766 | -$13 |